DOCSLIB.ORG

49 CFR Ch. I (10–1–97 Edition) § 172.101

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
49 CFR Ch. I (10–1–97 Edition) § 172.101 § 172.101 49 CFR Ch. I (10±1±97 Edition) TABLE 2.ÐRadionuclidesÐContinued TABLE 2.ÐRadionuclidesÐContinued (2)Ð (2)Ð Atomic (3)ÐReportable (3)ÐReportable (1)ÐRadionuclide Quantity (RQ) (1)ÐRadionuclide Atomic Quantity (RQ) Num- Ci (TBq) Num- ber ber Ci (TBq) Tungsten-179 ........................... 74 1000 (37) Zirconium-97 ............................ 40 10 (.37) Tungsten-181 ........................... 74 100 (3.7) Tungsten-185 ........................... 74 10 (.37) $ The RQs for all radionuclides apply to chemical com- pounds containing the radionuclides and elemental forms re- Tungsten-187 ........................... 74 100 (3.7) gardless of the diameter of pieces of solid material. Tungsten-188 ........................... 74 10 (.37) EEE² The RQ of one curie applies to all radionuclides not Uranium (Depleted) ................. 92 *** otherwise listed. Whenever the RQs in TABLE 1ÐHAZARD- Uranium (Irradiated) ................ 92 *** OUS SUBSTANCES OTHER THAN RADIONUCLIDES and Uranium (Natural) .................... 92 ** this table conflict, the lowest RQ shall apply. For example, Uranium Enriched 20% or great- uranyl acetate and uranyl nitrate have RQs shown in TABLE er .......................................... 92 *** 1 of 100 pounds, equivalent to about one-tenth the RQ level for uranium-238 in this table. Uranium Enriched less than ** The method to determine the RQs for mixtures or solu- 20% ...................................... 92 *** tions of radionuclides can be found in paragraph 6 of the note Uranium-230 ............................ 92 1 (.037) preceding TABLE 1 of this appendix. RQs for the following Uranium-231 ............................ 92 1000 (37) four common radionuclide mixtures are provided: radium-226 Uranium-232 ............................ 92 0.01 (.00037) in secular equilibrium with its daughters (0.053 curie); natural Uranium-233 ............................ 92 0.1 (.0037) uranium (0.1 curie); natural uranium in secular equilibrium with its daughters (0.052 curie); and natural thorium in secular Uranium-234 ** ........................ 92 0.1 (.0037) equilibrium with its daughters (0.011 curie). Uranium-235 ** ........................ 92 0.1 (.0037) *** Indicates that the name was added by RSPA because it Uranium-236 ............................ 92 0.1 (.0037) appears in the list of radionuclides in 49 CFR 173.435. The Uranium-237 ............................ 92 100 (3.7) reportable quantity (RQ), if not specifically listed elsewhere in Uranium-238 ** ........................ 92 0.1 (.0037) this appendix, shall be determined in accordance with the pro- Uranium-239 ............................ 92 1000 (37) cedures in paragraph 6 of this appendix. Uranium-240 ............................ 92 1000 (37) Vanadium-47 ........................... 23 1000 (37) [Amdt. 172±122, 55 FR 46798, Nov. 7, 1990] Vanadium-48 ........................... 23 10 (.37) Vanadium-49 ........................... 23 1000 (37) EDITORIAL NOTE: For FEDERAL REGISTER Xenon-120 ............................... 54 100 (3.7) citations affecting Appendix A to § 172.102, Xenon-121 ............................... 54 10 (.37) see the List of CFR Sections Affected in the Xenon-122 ............................... 54 100 (3.7) Finding Aids section of this volume. Xenon-123 ............................... 54 10 (.37) Xenon-125 ............................... 54 100 (3.7) Xenon-127 ............................... 54 100 (3.7) APPENDIX B TO § 172.101ÐLIST OF Xenon-129m ............................ 54 1000 (37) MARINE POLLUTANTS Xenon-131m ............................ 54 1000 (37) Xenon-133 ............................... 54 1000 (37) 1. This appendix lists potential marine pol- Xenon-133m ............................ 54 1000 (37) lutants as defined in § 171.8 of this sub- Xenon-135 ............................... 54 100 (3.7) chapter. Xenon-135m ............................ 54 10 (.37) Xenon-138 ............................... 54 10 (.37) 2. If a marine pollutant meets the defini- Ytterbium-162 .......................... 70 1000 (37) tion of any hazard class or division as de- Ytterbium-166 .......................... 70 10 (.37) fined in this subchapter, other than Class 9, Ytterbium-167 .......................... 70 1000 (37) the class of the material must be determined Ytterbium-169 .......................... 70 10 (.37) in accordance with § 173.2a of this sub- Ytterbium-175 .......................... 70 100 (3.7) chapter. Ytterbium-177 .......................... 70 1000 (37) Ytterbium-178 .......................... 70 1000 (37) 3. This appendix contains two columns. Yttrium-86 ................................ 39 10 (.37) The first column, entitled ``S.M.P.'' (for se- Yttrium-86m ............................. 39 1000 (37) vere marine pollutants), identifies whether a Yttrium-87 ................................ 39 10 (.37) material is a severe marine pollutant. If the Yttrium-88 ................................ 39 10 (.37) letters ``PP'' appear in this column for a ma- Yttrium-90 ................................ 39 10 (.37) terial, the material is a severe marine pol- Yttrium-90m ............................. 39 100 (3.7) Yttrium-91 ................................ 39 10 (.37) lutant, otherwise it is not. The second col- Yttrium-91m ............................. 39 1000 (37) umn, entitled ``Marine Pollutant'' , lists the Yttrium-92 ................................ 39 100 (3.7) marine pollutants. Yttrium-93 ................................ 39 100 (3.7) 4. If a material not listed in this appendix Yttrium-94 ................................ 39 1000 (37) meets the criteria for a marine pollutant, as Yttrium-95 ................................ 39 1000 (37) provided in the General Introduction of the Zinc-62 ..................................... 30 100 (3.7) IMDG Code, Guidelines for the Identification Zinc-63 ..................................... 30 1000 (37) Zinc-65 ..................................... 30 10 (.37) of Harmful Substances in Packaged Form, Zinc-69 ..................................... 30 1000 (37) the material may be transported as a marine Zinc-69m .................................. 30 100 (3.7) pollutant in accordance with the applicable Zinc-71m .................................. 30 100 (3.7) requirements of this subchapter. Zinc-72 ..................................... 30 100 (3.7) 5. If approved by the Associate Adminis- Zirconium-86 ............................ 40 100 (3.7) trator for Hazardous Materials Safety, a ma- Zirconium-88 ............................ 40 10 (.37) Zirconium-89 ............................ 40 100 (3.7) terial listed in this appendix which does not Zirconium-93 ............................ 40 1 (.037) meet the criteria for a marine pollutant, as Zirconium-95 ............................ 40 10 (.37) provided in the General Introduction of the 268 VerDate 02<DEC>97 12:44 Mar 09, 1998 Jkt 174192 PO 00000 Frm 00262 Fmt 8010 Sfmt 8010 Y:\SGML\174192.TXT 174192 Research and Special Programs Administration, DOT § 172.101 IMDG Code, Guidelines for the Identification APPENDIX B TO § 172.101 List of Marine of Harmful Substances in Packaged Form, is PollutantsÐContinued excepted from the requirements of this sub- chapter as a marine pollutant. S.M.P. Marine Pollutant APPENDIX B TO § 172.101 List of Marine (1) (2) Pollutants ...................... 2,6-Di-tert-butylphenol. ...................... para-tertiary-butyltoluene ...................... Butyraldehyde. S.M.P. Marine Pollutant PP ................ Cadmium compounds (1) (2) ...................... Cadmium sulphide ...................... Acetal ...................... Calcium arsenate ...................... Acetaldehyde. ...................... Calcium arsenate and calcium arsenite, mix- ...................... Acetone cyanohydrin, stabilized tures, solid ...................... Acetylene tetrabromide ...................... Calcium cyanide ...................... Acetylene tetrachloride ...................... Calcium naphthenate ...................... Acraldehyde, inhibited PP ................ Camphechlor ...................... Acrolein, inhibited ...................... Camphor oil. ...................... Acrylic aldehyde, inhibited ...................... Carbaryl ...................... Alcohol C-12 - C-15 poly(1-3) ethoxylate ...................... Carbendazim ...................... Alcohol C-13 - C-15 poly(1-6) ethoxylate ...................... Carbofuran ...................... Alcohol C-6 - C-17 (secondary)poly(3-6) ...................... Carbon tetrabromide ethoxylate ...................... Carbon tetrachloride ...................... Aldicarb PP ................ Carbophenothion PP ................ Aldrin ...................... Cartap hydrochloride ...................... Alkyl (c12-c14) dimethylamine PP ................ Chlordane ...................... Alkyl (c7-c9) nitrates ...................... Chlorfenvinphos ...................... Alkyl (C10-C21) sulphonic acid ester of phe- PP ................ Chlorinated paraffins (C-10 - C-13) nol. ...................... Chlorine ...................... Chlorine cyanide, inhibited ...................... Alkylphenols, liquid, n.o.s. (including C2-C8 ...................... Chlormephos homologues) ...................... Chloroacetone, stabilized ...................... Alkylphenols, solid, n.o.s. (including C2-C8 ...................... 2-Chloro-6-nitrotoluene homologues) ...................... 4-Chloro-2-nitrotoluene ...................... Allyl bromide ...................... Chloro-ortho-nitrotoluene ...................... ortho-Aminoanisole
Load more

Recommended publications
  • This Table of Gas and Materials Compatibility
    Materials Compatibility Section G – Technical Data Section G – Technical Gas Compatibility Directions The compatibility data shown on pages To use the compatibility chart on the 2 and 3 of this Section G have been following pages, proceed as follows: compiled to assist in evaluating ap- 1 3 propriate materials for use in handling various gases. It is extremely important Locate the gas you are using in the Refer to the applicable “Key to that all gas control equipment be com- first column of the chart. Materials Compatibility Symbol”. patible with the gas being used. The 2 4 use of a device that is not compatible Check the materials of construction Verify that the “Key to Materials may damage the unit and cause a leak you intend to use. Materials of Compatibility Symbol” allows this that could result in property damage Construction have been grouped by combination and that the application or personal injury. To reduce potentially metals, plastics and elastomers. is satisfactory. harmful situations, always check for the compatibility of equipment and materials before using any gases in Key to Materials Compatibility your gas control equipment. S – Satisfactory for use with the intended gas. Since combinations of gases are C – Conditional. May be incompatible under some circumstances or conditions. virtually unlimited, mixtures (except Contact your Praxair representative for additional information. for Oxyfume® and Medifume® steril- U – Unsatisfactory for use with the intended gas. izing gas mixtures) are not listed in the Compatibility Chart. Before using a I – Insufficient data available to determine compatibility with the gas mixture or any gas not listed in the intended gas.
    [Show full text]
  • Zinc, Magnesium and NMDA Receptor Alterations in the Hippocampus of Suicide Victims
    Journal of Affective Disorders 151 (2013) 924–931 Contents lists available at ScienceDirect Journal of Affective Disorders journal homepage: www.elsevier.com/locate/jad Research report Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims Magdalena Sowa-Kućma a,n, Bernadeta Szewczyk a, Krystyna Sadlik b, Wojciech Piekoszewski c,d, Franciszek Trela e,Włodzimierz Opoka f, Ewa Poleszak g, Andrzej Pilc a,h, Gabriel Nowak a,i a Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland b Institute of Forensic Research, Kraków, Poland c Department of Analytical Chemistry, Faculty of Chemistry, Jagiellonian University, Kraków, Poland d Laboratory of High Resolution Mass Spectrometry, Regional Laboratory of Physicochemical Analysis and Structural Research, Faculty of Chemistry, Jagiellonian University, Kraków, Poland e Department of Forensic Medicine, Jagiellonian University Medical College, Kraków, Poland f Department of Inorganic Chemistry, Jagiellonian University Medical College, Kraków, Poland g Department of Applied Pharmacy, Medical University of Lublin, Lublin, Poland h Institute of Public Health, Jagiellonian University Medical College, Kraków, Poland i Chair of Pharmacobiology, Jagiellonian University Medical College, Kraków, Poland article info abstract Article history: Background: There is evidence for an association between suicidal behavior and depression. Accumulat- Received 27 May 2013 ing data suggests that depression is related to a dysfunction of the brain's glutamatergic system, and that Received in revised form the N-methyl-D-aspartate (NMDA) receptor plays an important role in antidepressant activity. Zinc and 9 August 2013 magnesium, the potent antagonists of the NMDA receptor complex, are involved in the pathophysiology Accepted 9 August 2013 of depression and exhibit antidepressant activity.
    [Show full text]
  • Zinc-Magnesium Supplementation, Hormones and Strength
    Zinc-Magnesium Supplementation, Hormones and Strength JEPonline Journal of Exercise Physiologyonline Official Journal of The American Society of Exercise Physiologists (ASEP) ISSN 1097-9751 An International Electronic Journal Volume 3 Number 4 October 2000 Exercise Nutrition Effects of a Novel Zinc-Magnesium Formulation on Hormones and Strength L.R. BRILLA1 AND VICTOR CONTE2 1Exercise and Sports Science Laboratory, Western Washington University, Bellingham, WA 98225-9067 and 2BALCO Laboratories, 1520 Gilbreth Road, Burlingame, CA 94010, Tel: 800-777-7122 L.R. BRILLA AND VICTOR CONTE. Effects of a Novel Zinc-Magnesium Formulation on Hormones and Strength. JEPonline, 3(4): 26-36, 2000. Muscle attributes and selected blood hormones of football players were assessed in response to a nightly supplementation regimen during spring football, over an 8-week period, with pre-post measures. A double-blind randomized study was conducted with ZMA (30 mg zinc monomethionine aspartate, 450 mg magnesium aspartate, and 10.5 mg of vitamin B-6) and placebo (P), n=12 and n=15, respectively. Plasma zinc and magnesium levels were ZMA (0.80 to 1.04 mg/ml; 19.43 to 20.63 mcg/ml ) and P (0.84 to 0.80 mg/ml ; 19.68 to 18.04 mg/ml), respectively (P<0.001). Free testosterone increased with ZMA (132.1 to 176.3 pg/mL), compared to P (141.0 to 126.6 pg/mL) (P<0.001); IGF-I increased in the ZMA group (424.2 to 439.3 ng/mL) and decreased in P (437.3 to 343.3 ng/mL) (P<0.001).
    [Show full text]
  • Photocatalytic Bleaching of Evans Blue Over Zinc Oxide Particulate
    Indian Journal of Chemistry Vol. 46A, March 2007, pp. 432-435 8 Photocatalytic bleaching of Evans blue over Matsuo and Udea have used SrTiO3-TiO2 composite zinc oxide particulate system powder for the photocatalytic bleaching of methylene blue. Preparation and characterization of ZnO/TiO2, Sharad Kothari*, Preeti Ameta & Rameshwar Ameta photocatalyst and their photocatalytic activity were reported by Liao et al.9 PG Department of Chemistry, Government College, 10,11 Banswara 327 001, India Sehili et al. have investigated the photocatalytic Email: [email protected] transformation of chloroaromatic derivatives such as Received 10 May 2006; revised 31 January 2007 chlorophenol and dichlorobenzenes on ZnO involving the formation of an adduct between OH• radicals and Evans blue, an azo dye, and its mixture with amaranth are 12 degraded photocatalytically in presence of zinc oxide. The aromatic compound. Driessen et al. have studied optimum conditions for photobleaching of these dyes, like surface band(CB) and gas phase products and concentration of dye, pH, amount of semiconductor, light intermediates with FT-IR spectroscopy during intensity, etc., have been studied. During the photocatalytic photocatalytic oxidation of trichloroethylene on ZnO. degradation, the semiconductor (ZnO) remains unaffected as Synthesis and photocatalytic activity of ZnO/ZrO2 evident from its FT-IR. The studied dyes are commonly used in 13 dyeing, printing and textile industries and hence, the present work composite have been reported by Hsu and Wu. Riaj will be helpful in the treatment of coloured effluents from these et al.14 used ZnO as a photocatalyst for the industries. photocatalytic bleaching of rhodamine-6G. 8 Photocatalytic bleaching of Evan blue (EB) has not IPC Code: Int.
    [Show full text]
  • Magnesium, Iron, Zinc, Copper and Selenium Status in Attention-Deficit
    molecules Review Magnesium, Iron, Zinc, Copper and Selenium Status in Attention-Deficit/Hyperactivity Disorder (ADHD) Harry Robberecht *, Annelies A. J. Verlaet, Annelies Breynaert, Tess De Bruyne and Nina Hermans Laboratory of Nutrition and Functional Food Science, NatuRA (Natural Products and Food Research and Analysis), Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Wilrijk, Belgium; [email protected] (A.A.J.V.); [email protected] (A.B.); [email protected] (T.D.B.); [email protected] (N.H.) * Correspondence: [email protected]; Tel.: +00-32-3265-2706 Academic Editors: Alejandro Samhan-Arias and Valeria M. Nurchi Received: 8 July 2020; Accepted: 25 September 2020; Published: 27 September 2020 Abstract: In this study, we critically review the literature concerning the relation of Mg, Fe, Zn, Cu and Se and attention-deficit/hyperactivity disorder (ADHD). Elemental status is estimated using peripheral blood parameters, hair, urine, daily intake and response to supplementation. The observed associations between concentration levels of the elements Mg, Fe, Zn, Cu and Se and ADHD symptoms are contradictory. This is partly due to the heterogeneity and complexity of the disorder. As a trend, lower ferritin and zinc levels can be observed. However, this correlation is not causative, as illustrated by placebo-controlled trials reporting conflicting evidence on the efficacy of supplementation. Well-defined studies on changes in concentration levels of the elements in relation to ADHD symptoms before and after treatment with therapeutics it will be possible to shed more light on the significance of these elements in this behavioral disorder. The discussion on whether a change in concentration of an element is cause or consequence of ADHD is not within the scope of this article.
    [Show full text]
  • The Interaction of Selective A1 and A2A Adenosine Receptor Antagonists with Magnesium and Zinc Ions in Mice: Behavioural, Biochemical and Molecular Studies
    International Journal of Molecular Sciences Article The Interaction of Selective A1 and A2A Adenosine Receptor Antagonists with Magnesium and Zinc Ions in Mice: Behavioural, Biochemical and Molecular Studies Aleksandra Szopa 1,* , Karolina Bogatko 1, Mariola Herbet 2 , Anna Serefko 1 , Marta Ostrowska 2 , Sylwia Wo´sko 1, Katarzyna Swi´ ˛ader 3, Bernadeta Szewczyk 4, Aleksandra Wla´z 5, Piotr Skałecki 6, Andrzej Wróbel 7 , Sławomir Mandziuk 8, Aleksandra Pochodyła 3, Anna Kudela 2, Jarosław Dudka 2, Maria Radziwo ´n-Zaleska 9, Piotr Wla´z 10 and Ewa Poleszak 1,* 1 Chair and Department of Applied and Social Pharmacy, Laboratory of Preclinical Testing, Medical University of Lublin, 1 Chod´zkiStreet, PL 20–093 Lublin, Poland; [email protected] (K.B.); [email protected] (A.S.); [email protected] (S.W.) 2 Chair and Department of Toxicology, Medical University of Lublin, 8 Chod´zkiStreet, PL 20–093 Lublin, Poland; [email protected] (M.H.); [email protected] (M.O.); [email protected] (A.K.) [email protected] (J.D.) 3 Chair and Department of Applied and Social Pharmacy, Medical University of Lublin, 1 Chod´zkiStreet, PL 20–093 Lublin, Poland; [email protected] (K.S.);´ [email protected] (A.P.) 4 Department of Neurobiology, Polish Academy of Sciences, Maj Institute of Pharmacology, 12 Sm˛etnaStreet, PL 31–343 Kraków, Poland; [email protected] 5 Department of Pathophysiology, Medical University of Lublin, 8 Jaczewskiego Street, PL 20–090 Lublin, Poland; [email protected] Citation: Szopa, A.; Bogatko, K.; 6 Department of Commodity Science and Processing of Raw Animal Materials, University of Life Sciences, Herbet, M.; Serefko, A.; Ostrowska, 13 Akademicka Street, PL 20–950 Lublin, Poland; [email protected] M.; Wo´sko,S.; Swi´ ˛ader, K.; Szewczyk, 7 Second Department of Gynecology, 8 Jaczewskiego Street, PL 20–090 Lublin, Poland; B.; Wla´z,A.; Skałecki, P.; et al.
    [Show full text]
  • PREPARATION of C-Tio2 NANOPHOTOCATALYST and ITS USED for DEGRADATION of EVANS BLUE
    Sci. Revs. Chem. Commun.: 6(1), 2016, 12-18 ISSN 2277-2669 PREPARATION OF C-TiO2 NANOPHOTOCATALYST AND ITS USED FOR DEGRADATION OF EVANS BLUE PREETI S. PILLAIa, DINESH I. PRAJAPATIb, RAKSHIT AMETAa and YASMIN ALI* Department of Chemistry, Techno-NJR Institute of Technology, UAIPUR (Raj) INDIA aDepartment of Chemistry, PAHER University, UDAIPUR (Raj.) INDIA bDepartment of Chemistry, M. G. Science Institute, AHMEDABAD (Guj.) INDIA (Received : 08.03.2016; Accepted : 20.03.2016) ABSTRACT The present work incorporates the study of efficiency of carbon doped TiO2 for photocatalytic degradation of Evans blue dye. Effect of some factors such as catalyst dose, concentration of dye, intensity of light, pH etc., on degradation of the dye was examined. The reaction followed pseudo first order kinetics. Participation of •OH free radical was confirmed by scavenger studies. Optimum conditions were determined by variation of operational parameters. A tentative mechanism for photocatalytic degradation of Evans Blue has been proposed. Key words: Carbon doped TiO2, Photocatalytic degradation, Evans blue dye. INTRODUCTION Water pollution is increasing day by day, which attracted the attention of many resercheres on this subject. Out of various technique used for the removal of toxic substance, photocatalytic method has emerged as most effective and promising technique. Photcatalytic degradation of basic blue –24 and orange- G over ZnO powder in the presence of surfactant was been reported by Ameta et al.1 Rao et al.2 observed the photocatalytic degradation of crystal violet in aqueous suspension of zinc oxide. Papadam et al.3 worked on photocatalytic converstion of acid orange 20 and Cr (VI) in aqueous TiO2.
    [Show full text]
  • The Effects of Combined Magnesium and Zinc Supplementation On
    Hamedifard et al. Lipids in Health and Disease (2020) 19:112 https://doi.org/10.1186/s12944-020-01298-4 RESEARCH Open Access The effects of combined magnesium and zinc supplementation on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease Zahra Hamedifard1, Alireza Farrokhian2, Željko Reiner3, Fereshteh Bahmani1, Zatollah Asemi1, Maryam Ghotbi1 and Mohsen Taghizadeh1* Abstract Background: The present research aimed to analyze the impacts of magnesium and zinc supplements on glycemic control, serum lipids, and biomarkers of oxidative stress and inflammation in patients suffering from coronary heart disease (CHD) and type 2 diabetes mellitus (T2DM). Methods: According to the research design, a randomized, double-blind, placebo-controlled trial has been implemented on 60 subjects suffering from CHD and T2DM. Therefore, participants have been randomly divided into 2 groups for taking placebo (n = 30) or 250 mg magnesium oxide plus 150 mg zinc sulfate (n = 30) for 12 weeks. Results: Magnesium and zinc significantly decreased fasting plasma glucose (FPG) (β − 9.44 mg/dL, 95% CI, − 18.30, − 0.57; P = 0.03) and insulin levels (β − 1.37 μIU/mL, 95% CI, − 2.57, − 0.18; P = 0.02). Moreover, HDL-cholesterol levels significantly enhanced (β 2.09 mg/dL, 95% CI, 0.05, 4.13; P = 0.04) in comparison to the placebo. There was an association between magnesium and zinc intake, and a significant decrease of C-reactive protein (CRP) (β − 0.85 mg/L, 95% CI, − 1.26, − 0.45; P < 0.001), a significant increase in total nitrite (β 5.13 μmol/L, 95% CI, 1.85, 8.41; P =0.003)and total antioxidant capacity (TAC) (β 43.44 mmol/L, 95% CI, 3.39, 83.50; P = 0.03) when compared with placebo.
    [Show full text]
  • The Absorption and Retention of Magnesium, Zinc, and Copper by Low Birth Weight Infants Fed Pasteurized Human Breast Milk
    Pediat. Res. 11: 991-997 (1977) Absorption magnesium copper newborn low birth weight infants zinc The Absorption and Retention of Magnesium, Zinc, and Copper by Low Birth Weight Infants Fed pasteurized Human Breast Milk M. J. DAUNCEY, J. C. L. SHAW,'3" AND J. URMAN Depnrttnent of Poedintrics, University College Hospitnl, Londorz, and Medical Resenrcll Council Dicnn Nutrition Unit, Cilmbridge, England Summary about two-thirds of the magnesium and perhaps one-third of the zinc in the body are present in the bones. Because of the " Using serial metabolic balance techniques, the absorption and extensive remodeling of fetal bone after birth retention of magnesium, copper, and zinc have been measured much of the magnesium and zinc in bone, as well as the hepatic in six preterm infants (mean gestation 29 weeks), and two term copper, probably become available to meet the later needs of the , small for gestational age infants (<1.5 kg birth weight). The growing full term infant. amounts of the minerals retained were compared with the The infant born months prematurely, however, has much amounts retained by a fetus of equivalent ~e~~~~~~~~lage in smaller amounts of magnesium, copper, and zinc in his body, u tero . and must rely on the fetal intestine to absorb enough of these The preterm absorbed 5'3 * 3'5 mg/kg'day "lagne- substances for his needs. Cavell and Widdowson (4) showed that sium (43% of intake, range 1-74%) and retained 2.8 * 1.3 mg/ full term infants were in negative balance for copper and zinc in kg' (25% intake, range -I5 to +48%)' The mean postna- the newborn period, and the reports of Tkacenko (21) and of tal retention over the period, as a percentage of Widdowson et a/.
    [Show full text]
  • Zinc in Drinking-Water
    WHO/SDE/WSH/03.04/17 English only Zinc in Drinking-water Background document for development of WHO Guidelines for Drinking-water Quality __________________ Originally published in Guidelines for drinking-water quality, 2nd ed. Vol. 2. Health criteria and other supporting information. World Health Organization, Geneva, 1996. © World Health Organization 2003 All rights reserved. Publications of the World Health Organization can be obtained from Marketing and Dissemination, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: [email protected]). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to Publications, at the above address (fax: +41 22 791 4806; email: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. The World Health Organization does
    [Show full text]
  • A Flexible Zinc Tetrazolate Framework with Breathing Behaviour on Xenon Adsorption and Selective Adsorption of Xenon Over Other Noble Gases
    Electronic Supplementary Material (ESI) for Journal of Materials Chemistry A. This journal is © The Royal Society of Chemistry 2015 Electronic Supplementary Material (ESI) for J. Mater. Chem. A. Supporting Information A flexible zinc tetrazolate framework with breathing behaviour on xenon adsorption and selective adsorption of xenon over other noble gases Shunshun Xionga, Qiang Liua, Qian Wanga, Wei Lia, Yuanming Tanga, Xiaolin Wang a*, Sheng Hua*, and Banglin Chenb aInstitute of Nuclear Physics and Chemistry, China Academy of Engineering Physics, Mianyang, Sichuan, 621900, P. R. China;E-mail:[email protected], [email protected]. bDepartment of Chemistry, University of Texas at San Antonio, One UTSA Circle, San Antonio, Texas 78249-069, United States. S1 Table S1. Crystal data and structure refinement for [Zn(mtz)2] [Zn(mtz)2] chemical formula C16H24N32Zn4 formula weight 926.15 temperature (K) 293(2) wavelength (Å) 0.71073 crystal system monoclinic space group Pc a (Å) 19.2148(14) b (Å) 13.3436(8) c (Å) 10.6713(5) α (º) 90.00 β (º) 95.038(6) γ (º) 90.00 V (Å3) 2725.5(3) Z 2 density (calculated g/cm-3) 1.129 absorbance coefficient (mm-1) 1.781 F(000) 928 crystal size (mm3) 0.36×0.33×0.32 goodness of fit on F2 1.007 Rint 0.0407 R1, wR2 (I>2σ(I)a 0.0486, 0.1270 R1, wR2 (all data)a 0.0780, 0.1374 a 2 2 1/2 R1 = Σ(|Fo| - |Fc|) /Σ|Fo|; wR2 =|Σw(|Fo|-|Fc| ) /ΣwFo ] S2 Figure S1. The N2 sorption isotherm for [Zn(mtz)2] at 77K.
    [Show full text]
  • Early Refill Drug Utilization Review Drugs
    Early Refill Drug Utilization Review Drugs Published: 05/01/2012 Point-of-Sale Drug Authorization and Policy Drug Name Effective Date Override Override Center Override Acarbose X 11/8/2008 Acebutolol hydrochloride X 11/8/2008 acetaminophen X 11/8/2008 acetazolamide X 11/8/2008 acetazolamide sodium X 11/8/2008 acetylcholine X 11/8/2008 acetylcysteine X 11/8/2008 Acitretin X 11/8/2008 Acrivastine X 11/8/2008 activated charcoal X 11/8/2008 adalimumab X 11/8/2008 Adapalene X 11/8/2008 Adenosine X 11/8/2008 albumin human X 11/8/2008 Albuterol X 11/8/2008 albuterol sulfate X 11/8/2008 alclometasone dipropionate X 11/8/2008 aldesleukin X 11/8/2008 alendronate sodium X 11/8/2008 alfentanil hydrochloride X 11/8/2008 aliskiren hemifumarate X 11/8/2008 Alitretinoin X 11/8/2008 almotriptan malate X 11/8/2008 alosetron hydrochloride X 11/8/2008 Alprazolam X 1/6/2010 Aluminum X 11/8/2008 aluminum sulfate X 11/8/2008 amantadine hydrochloride X 11/8/2008 amcinonide X 11/8/2008 amino acids X 11/8/2008 aminophylline X 11/8/2008 amiodarone hydrochloride X 11/8/2008 amitriptyline hydrochloride X 11/8/2008 amlodipine besylate X 11/8/2008 Ammonium X 11/8/2008 Ammonium chloride X 11/8/2008 amobarbital X 1/6/2010 Point-of-Sale Drug Authorization and Policy Drug Name Effective Date Override Override Center Override Amoxicillin trihydrate X 11/8/2008 amphetamine X 1/6/2010 amyl nitrite X 11/8/2008 Amylase X 11/8/2008 apraclonidine hydrochloride X 11/8/2008 arformoterol tartrate X 11/8/2008 Arginine X 11/8/2008 arginine hydrochloride X 11/8/2008 aripiprazole X
    [Show full text]